TREAT: Darbepoetin alfa does not reduce outcomes of death, CV events or end ... - Cardiology Today PDF Print
Cardiology TodayThe administration of darbepoetin alfa was not associated with a reduction in death, cardiovascular events or end-stage renal disease, according to results

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.